Skip to content
Menu

Veracyte, Inc. VCYT

Full chart Compare
Set alert

Price alert · VCYT

All alert types
24.23 USD +0.22 (+0.92%)

Regular-session close

23.89 -0.34 -1.40%

After hours · Nov 17, 4:00 PM ET

23.60 Day range 24.47
21.91 52-week range 60.91
YTD
-42.45%
1 year
-38.31%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Gross Profit$360.05MCost of Revenue$157.10MNet Income$66.35MSelling, General & Admin$210.95MResearch & Development$70.81MOther Operating Expenses$4.13MOther Expenses$5.95MIncome Tax$1.85MRevenue$517.14MTesting$493.15MProduct$14.33MBiopharmaceutical And Other$9.66M

Latest period ending Dec 31, 2025 · select a line to chart its full history

VCYT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
517.14M445.76M361.05M296.54M219.51M
362.53M298.14M229.68M175.68M145.11M
57.78M16.14M-85.80M-41.08M-81.90M
66.35M24.14M-74.40M-36.56M-75.56M
0.820.31-1.02-0.51-1.11
VCYT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
364.23M240.63M217.33M155.00M173.95M
1.41B1.30B1.11B1.16B1.19B
96.44M124.07M70.80M81.22M91.31M
39.65M50.74M12.63M14.72M18.85M
1.31B1.18B1.04B1.08B1.10B
VCYT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
136.31M75.10M44.22M7.54M-31.62M
-9.21M-56.27M15.11M-29.39M-739.21M
-4.22M4.90M2.84M3.49M596.32M
-9.68M-11.29M-9.96M-8.55M-5.38M
122.88M23.73M62.17M-18.36M-174.51M